Lakefront Biotherapeutics NV

LKFT·NasdaqGS·Healthcare
Compare
29.57−0.16 (−0.54%)today
At close: Oct 12, 4:00 PM EDT · May be delayed up to 15 min · USD
After hours29.570.00 (0.00%)Oct 12, 4:01 PM EDT

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close29.73
Open29.65
Day range29.4729.93
52-week range25.6836.24
Off day high−1.19%
Off 52-week high−18.41%
Volume220.25K
Avg. volume (3M)274.48K
Market cap1.94B
EPS (TTM)10.52
Forward P/E-24.90
P/E ratio (TTM)2.81
Dividend yield—
Beta (5Y)0.06
Shares outstanding65.48M
Short interest8.28% of float
Earnings dateNov 11, 2026
Analyst target30.10
Profit margin60.23%

Against its peers

Compare in full ›
LKFT BHVN SLS NKTR LEGN IOVA
Market cap 1.94B 1.78B 2.41B 1.36B 3.46B 6.60B
P/E (TTM) 2.8 — — — — —
Forward P/E -24.9 -6.3 -119.3 -3.9 17.0 -67.9
Price/book 10.5 145.8 17.5 1.5 2.8 9.0
Dividend yield — — — — — —
1-year change −12.35% −29.11% +481.95% −28.28% −43.32% +583.18%
Today −0.54% −2.24% +2.40% −3.23% −4.40% −0.41%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.

Latest news

All LKFT news ›
cyprus-mail.com·Positive

Demetra Holdings buys back 5,057 of its own shares

Demetra Holdings Plc bought back 5,057 of its own shares on October 9, 2026, at an average price of €1.35 per share, the company announced on Monday. The purchases were carried out through the Cyprus Investment & Securities Corporation Ltd…

MarketScreener·Positive

Lakefront Biotherapeutics NV : Insider Transactions

Follow insider transactions on Lakefront Biotherapeutics NV in real time. Filter by importance or transaction type and analyze the history on MarketScreener. Insider Transactions Lakefront Biotherapeutics NV Biotechnology & Medical…

Philstar.com·Negative

Owners buy their stocks

Last month, Mitsubishi Corp finalized a deal for the acquisition of a 10 percent stake in AC through a partial tender offer. In this case, the buyer is not a majority owner but a business partner of the Ayala group. The transaction value…

TradingView·

Total current assets of Lakefront Biotherapeutics – XETR:GXE

Lakefront Biotherapeutics is a biotechnology company, which engages in the identification and development of small molecule and antibody therapies. Its clinical pipeline includes filgotinib, GLP3667, Toledo program, and idiopathic…

From articles in the 4Search news index.

In the news

73mentions in 30 days
19with it in the headline
Positivesentiment

Finance and business coverage in the 4Conservative news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 73 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Conservative index. Terms of use.